104075-48-1 Atipamezole HCl AKSci J61470
 
 
Loading Please Wait...
  J61470    
Atipamezole HCl
, 95%
 
1H-Imidazole, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-, monohydrochloride




IDENTITY
CAS Number:104075-48-1
MDL Number:MFCD06407819
MF:C14H17ClN2
MW:248.75
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:95%
Physical Form (at 20°C):Solid
Melting Point:211-225°C
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:Soluble in water (100 mM) and DMSO (100 mM)
Application(s):A selective alfa2-adrenergic receptor antagonist
Form:HCl salt

REVIEW

 Atipamezole (brand name Antisedan, Pfizer) is a synthetic alpha2-adrenergic antagonist with an imidazole structure, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. It has also been researched in humans as a potential anti-Parkinsonian drug. Receptor binding studies indicate that its affinity for alpha2-adrenoceptors and its alpha2/alpha1 selectivity ratio are considerably higher than those of yohimbine, the prototype alpha2-adrenoceptor antagonist. Atipamezole is not selective for subtypes of alpha2-adrenoceptors. Unlike many other alpha2-adrenoceptor antagonists, it has negligible affinity for 5-HT1A and I2 binding sites.

REFERENCES
[1]Karjalainen, Arto Johannes; Virtanen, Raimo Einari; Karjalainen, Arja Leena; Kurkela, Kauko Oiva Antero Substituted imidazole derivatives and their use Eur. Pat. Appl. (1986), EP 183492 A1 19860604.
[2] Honkavaara, Juhana M.; Raekallio, Marja R.; Kuusela, Erja K.; Hyvarinen, Esko A.; Vainio, Outi M. The effects of L-659,066, a peripheral alpha2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs Veterinary Anaesthesia and Analgesia (2008), 35(5), 409-413.
[3] Talukder, Md. Hasanuzzaman; Hikasa, Yoshiaki; Takahashi, Hajime; Sato, Kanako; Matsuu, Aya Antagonistic effects of atipamezole and yohimbine on medetomidine-induced diuresis in healthy dogs. Canadian Journal of Veterinary Research (2009), 73(4), 260-270.
[4] Pertovaara A, Haapalinna A, Sirviö J, Virtanen R. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. CNS Drug Rev. 2005 Autumn;11(3):273-88.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


Current as of May 19, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Alpha Blockers


PubChem
  @PubMed